A consortium comprised of the University of Cyprus, the Cyprus University of Technology, the European University of Cyprus and Theramir Ltd has been awarded an infrastructure grant from the Research Promotion Foundation to establish a joint “Center for Preclinical Evaluation and Optimization of Cancer Nanomedicines,” which aims to investigate nanoparticle formulations in the preclinical drug development stage. The project will be funded for 48 months under the RPF program call “New Strategic Infrastructure Units,” and has a total budget of €995,812.